Efficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studies
© Berhan and Berhan; licensee BioMed Central Ltd. 2013
Received: 19 September 2012
Accepted: 27 February 2013
Published: 1 March 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|19 Sep 2012||Submitted||Original manuscript|
|11 Oct 2012||Reviewed||Reviewer Report - Apostolos Tsapas|
|11 Nov 2012||Reviewed||Reviewer Report - Abd Tahrani|
|17 Nov 2012||Reviewed||Reviewer Report - marc rendell|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|16 Dec 2012||Reviewed||Reviewer Report - Apostolos Tsapas|
|17 Dec 2012||Reviewed||Reviewer Report - marc rendell|
|19 Dec 2012||Reviewed||Reviewer Report - Abd Tahrani|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|15 Jan 2013||Author responded||Author comments - Yifru Berhan|
|28 Jan 2013||Reviewed||Reviewer Report - Apostolos Tsapas|
|30 Jan 2013||Reviewed||Reviewer Report - marc rendell|
|Resubmission - Version 4|
|15 Jan 2013||Submitted||Manuscript version 4|
|27 Feb 2013||Editorially accepted|
|1 Mar 2013||Article published||10.1186/1472-6823-13-9|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.